The use of β-agonists and the risk of death and near death from asthma

New England Journal of Medicine

Volumn 326, Issue 8, 1992, Pages 501-506

  Suissa, Samy ^a,b   Ernst, Pierre ^a,b   Boivin, Jean François ^a   Horwitz, Ralph I ^a,c   Habbick, Brian ^a   Cockcroft, Donald ^a   Mcnutt, Mary ^d   Buist, A Sonia ^e   Rebuck, Anthony S ^f   Spitzer, Walter O ^a  

^a Department of Biostatistics ^*

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; SALBUTAMOL; THEOPHYLLINE;

ADULT; AEROSOL; ARTICLE; ASTHMA; CANADA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE; DRUG FATALITY; DRUG THERAPY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FENOTEROL; HUMAN; INSURANCE, HEALTH; MALE; NEBULIZERS AND VAPORIZERS; ODDS RATIO; SASKATCHEWAN; SUPPORT, NON-U.S. GOV'T;

EID: 0026595475     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199202203260801     Document Type: Article

References (27)

1. Crane J., Pearce N., Flatt A., et al. Prescribed fenoterol and death from asthma in New Zealand, 1981—83: case–control study. Lancet 1989; 1:917-922
2. Pearce N., Grainger J., Atkinson M., et al. Case–control study of prescribed fenoterol and death from asthma in New Zealand, 1977—81. Thorax 1990; 45:170-175
3. Grainger J., Woodman K., Pearce N., et al. Prescribed fenoterol and death from asthma in New Zealand, 1981—7: a further case–control study. Thorax 1991:46;105-11.
4. Sears M.R., Taylor D.R., Print C.G., et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336:1391-1396
5. Horwitz R.I., Spitzer W., Buist S., et al. Clinical complexity and epidemiologic uncertainty in case–control research: fenoterol and asthma management. Chest 1991; 100:1586-1591
6. West R. Saskatchewan health data bases: a developing resource. Am J Prev Med 1987; 4:Suppl 2:25-27
7. Strand L.M., West R. Health databases in Saskatchewan. In: Strom B, ed. Pharmacoepidemiology: the sciences of post-marketing drug surveillance. New York: Churchill Livingstone, 1989: 189-200.
8. Department of Health and Human Services. The international classification of diseases, 9th revision, clinical modification: ICD-9-CM. Vol. 1. Diseases: alphabetic index. 2nd ed. Washington, D.C.: Department of Health and Human Services, 1980. (DHHS publication no. (PHS) 80–1260.)
9. Breslow N.E., Day N.E. Statistical methods in cancer research. Vol. 2. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publications no. 82.)
10. Idem. Statistical methods in cancer research. Vol. 1. The analysis of case–control studies. Lyon, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)
11. Storer B.E., Crowley J. A diagnostic for Cox regression and general conditional likelihoods. J Am Stat Assoc 1985; 80:139-147
12. Rothman K.J., ed. Modern epidemiology. Boston: Little, Brown, 1986.
13. Poynter D. Fatal asthma — is treatment incriminated? J Allergy Clin Immunol 1987; 80:423-427
14. Olsson O.A.T., Swanberg E., Svedinger I., Waldeck B. Effects of beta-adrenoceptor agonists on airway smooth muscle and on slow-contracting skeletal muscle: in vitro and in vivo results compared. Acta Pharmacol Toxicol (Copenh) 1979; 44:272-276
15. Zaagsma J., van der Heijden P.J.C.M., van der Schaar M.W.G., Bank C.M.C. Differentiation of functional adrenoceptors in human and guinea pig airways. Eur J Respir Dis Suppl 1984; 135:16-33.
16. Wong C.S., Pavord I.D., Williams J., Britton J.R., Tattersfield A.E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 1990; 336:1396-1399
17. Arai Y., Nitta T., Shida T., Shioda H. Anti-asthmatic effects and drug tolerance of selective beta-2-adrenergic stimulants in guinea pigs. Eur J Respir Dis Suppl 1983; 128:506-508
18. Tang O.T., Flatley M. A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol. Postgrad Med J 1984; 60:Suppl 1:24-27
19. Salome C.M., Wright W., Sedgwick C.G., Woolcock A.J. Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone or in combination on hyperresponsiveness in asthmatic subjects. In: Armour CL, Black JL, eds. Mechanisms in asthma: pharmacology, physiology, and management. Vol. 263 of Progress in clinical and biological research. New York: Alan R. Liss, 1988: 405-19.
20. Hockley B., Johnson N.M. Fenoterol versus salbutamol nebulization in asthma. Postgrad Med J 1983; 59:504-505
21. Speizer F.E., Wegman D.H., Ramirez A. Palpitation rates associated with fluorocarbon exposure in a hospital setting. N Engl J Med 1975; 292:624-626
22. Lulich K.M., Goldie R.G., Ryan G., Paterson J.W. Adverse reactions to beta-2-agonist bronchodilators. Med Toxicol 1986; 1:289-299
23. Molfino N.A., Nannini L.J., Martelli A.N., Slutsky A.S. Respiratory arrest in near-fatal asthma. N Engl J Med 1991; 324:285-288
24. Kraan J., Koëter G.H., v d Mark T.W., Sluiter H.J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76:628-636
25. Kerrebijn K.F., van Essen-Zanduliet E.E.M., Neijens H.J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79: 653-9.
26. van Schyek C.P., Graafsma S.J., Visch M.B., Dompeling E., van Weel C., van Herwaarden C.L.A. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 1990; 86:792-800.
27. Sterk P.J., Bel E.H. The shape of the dose–response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:1433-1437